Sign Up to like & get
recommendations!
1
Published in 2022 at "Drug Delivery"
DOI: 10.1080/10717544.2022.2149899
Abstract: Abstract Pirfenidone (PRF) is the first FDA-approved API in the treatment of idiopathic pulmonary fibrosis (IPF). However, PRF induces serious side effects, such as photophobia and gastrointestinal disorder. PRF inhalation can be expected with a…
read more here.
Keywords:
spray;
pharmacodynamic study;
spray dried;
pharmacokinetic pharmacodynamic ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "International Journal of Nanomedicine"
DOI: 10.2147/ijn.s195048
Abstract: Background Apremilast (APM) is a novel, orally administered small molecule drug approved for treatment of psoriasis or psoriatic arthritis. Due to its low solubility and permeability, it is classified as a class IV drug according…
read more here.
Keywords:
apremilast;
vivo pharmacokinetic;
plga nanoparticles;
sustained release ... See more keywords